Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Trade Show, Webcast, Advisory

DiaMedica Therapeutics to Present at the Oppenheimer 33rd Annual Healthcare Conference


DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and kidney diseases, today announced that Rick Pauls, its President and CEO will present a corporate overview at the virtual Oppenheimer 33rd Annual Healthcare Conference, which will take place March 13th ? 15th, 2023.

Mr. Pauls is scheduled to present at 2:40 p.m. Eastern Time on Wednesday, March 15, 2023. In addition to the presentation, Mr. Pauls will be available for one-on-one investor meetings throughout the conference. Investors that are interested in arranging a meeting should contact their Oppenheimer representative.

About DiaMedica Therapeutics Inc.

DiaMedica Therapeutics Inc. is a clinical stage biopharmaceutical company committed to improving the lives of people suffering from serious diseases. DiaMedica's lead candidate DM199 is the first pharmaceutically active recombinant (synthetic) form of the KLK1 protein, an established therapeutic modality in Asia for the treatment of acute ischemic stroke and chronic kidney disease. For more information visit the Company's website at www.diamedica.com.


These press releases may also interest you

at 12:00
Blue Diamond and Brightseed Partner To Discover the Spectrum of Health-Benefiting Bioactive Compounds in California Almonds
Blue Diamond®, the world's leading almond marketer and processor, and Brightseed, the bioactives company and a World Economic Forum Global Innovator, today announce their partnership to discover the untapped health potential of nonpareil California...

at 12:00
Renowned Non-Surgical Rhinoplasty Specialist, Dr. Alexander Rivkin, Introduces Liquid Rhinoplasty with Permanent Results
Many individuals seek rhinoplasty to improve the aesthetic appearance of their noses. They may feel self-conscious about a nose that they perceive as too large, crooked, asymmetrical, or with a hump or bump. Rhinoplasty can reshape...

at 12:00
MDM Wound Ventures Appoints Mr. Jamie Hong as Chief Executive Officer
MDM Wound...

at 12:00
Disabled Veterans National Foundation awards $357,000 in Capacity Building Grants to 25 non-profit veteran support organizations
The Disabled Veterans National Foundation is pleased to announce that this spring, the organization will award $357,000 in grants to twenty-five non-profit veteran support organizations. With this funding, these organizations can offer a wide variety...

at 11:56
MRES: Institute of Biomedical Research unveils artificial intelligence (AI) powered initiatives within its CBD product range, psilocybin research, and cardiometabolic health solutions
Institute of Biomedical Research Corp. ("Institute of Biomedical Research" or the "Company"), a nutraceutical biotechnology company focused on alternative plant-based cannabinoids, medical psilocybin, and mental health therapeutic research in...

at 11:51
Karoo Health Raises $3.4 Million in Oversubscribed Seed Round
Karoo Health, the only provider of cardiac value-based care enablement, announced today the closing of an oversubscribed Seed round of $3.4 million, with First Trust Capital Partners, LLC as lead investor. The investment supports Karoo's launch this...

More news about Health...


News published on and distributed by: